Chromocell Therapeutics CorporationChromocell Therapeutics CorporationChromocell Therapeutics Corporation

Chromocell Therapeutics Corporation

No trades
See on Supercharts
Market capitalization
‪10.32 M‬USD
−1.27USD
‪−7.38 M‬USD
‪1.69 M‬
Beta (1Y)
1.62

About Chromocell Therapeutics Corporation

CEO
Francis P. Knuettel
Headquarters
07728
Employees (FY)
8
Founded
2021
FIGI
BBG01C9YP5V5
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CHRO is 1.77 USD — it has decreased by 1.12% in the past 24 hours. Watch Chromocell Therapeutics Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Chromocell Therapeutics Corporation stocks are traded under the ticker CHRO.
CHRO stock is 2.56% volatile and has beta coefficient of 1.62. Track Chromocell Therapeutics Corporation stock price on the chart and check out the list of the most volatile stocks — is Chromocell Therapeutics Corporation there?
Yes, you can track Chromocell Therapeutics Corporation financials in yearly and quarterly reports right on TradingView.
CHRO stock has risen by 18.00% compared to the previous week, the month change is a 33.21% fall, over the last year Chromocell Therapeutics Corporation has showed a 70.50% decrease.
CHRO net income for the last quarter is ‪−4.04 M‬ USD, while the quarter before that showed ‪−1.42 M‬ USD of net income which accounts for −184.10% change. Track more Chromocell Therapeutics Corporation financial stats to get the full picture.
No, CHRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chromocell Therapeutics Corporation stock right from TradingView charts — choose your broker and connect to your account.
CHRO reached its all-time high on Feb 16, 2024 with the price of 6.00 USD, and its all-time low was 1.21 USD and was reached on Apr 18, 2024. View more price dynamics on CHRO chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 8.00 employees. See our rating of the largest employees — is Chromocell Therapeutics Corporation on this list?